Identifying the Local Emergence of Medetomidine Through Prehospital Collaborations
Medetomidine, an emerging adulterant, further complicates the clinical care of exposed patients in overdose and magnifies features of xylazine exposure. In this case, prehospital data and clinical observation led to the identification of medetomidine in our community. With appropriate analytical toxicology resources, pre-hospital providers can translate clinical observation into new drug or adulterant identification, improving clinical care and public health.
Authors
- John Broach (ORCID: https://orcid.org/0000-0002-6581-2232)
- Michael D. Hunter (ORCID: https://orcid.org/0000-0002-3668-6476)
- Ronald Gigliotti
- Alex J. Krotulski (ORCID: https://orcid.org/0000-0003-1775-1882)
- Roland C. Merchant (ORCID: https://orcid.org/0000-0001-7571-1294)
- Stacy N. Weisberg
- Barry Kerr Logan (ORCID: https://orcid.org/0000-0003-2400-4711)
- Kavita M. Babu (ORCID: https://orcid.org/0000-0002-2908-0468)
- Brittany Chapman (ORCID: https://orcid.org/0000-0001-5761-5135)
- Patricia Mae Martinez
- John Nguyen (ORCID: https://orcid.org/0000-0001-9677-4876)
- Sara A. Walton (ORCID: https://orcid.org/0009-0007-3755-0451)
- Brian Rettger
- Jyothi Polackal
- Deborah Olabisi
- Brian Cotoni
Institutions
- UMass Memorial Health Care (US)
- University of Massachusetts Chan Medical School (US)
- Worcester Recovery Center and Hospital (US)
- Memorial Medical Center (US)
- Institute of Forensic Science (CN)
- UMass Memorial Medical Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Prehospital Emergency Care
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1080/10903127.2025.2491752
- Primary Topic
- Poisoning and overdose treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00